Stephen Gottschalk is an Oncology physician affiliated with St. Jude Children's Research Hospital. OpenAlex indexes 707 publications with 21,805 citations (h-index 79); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pediatric Hematology-Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
262 Danny Thomas Pl
Memphis, TN 381053678
Telephone
901-595-3300Provider last certified this registry record 11 Jan 2025.
Clinical trials
- Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
Sponsor: St. Jude Children's Research Hospital
- Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
Sponsor: St. Jude Children's Research Hospital
- Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products
Sponsor: St. Jude Children's Research Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- National Marrow Donor ProgramProgram year20251 payment
- National Marrow Donor ProgramProgram year20243 payments
- National Marrow Donor ProgramProgram year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2018–2025 per NIH RePORTER. The latest:
- Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors
St. Jude Children'S Research Hospital
FY2025$754,519R01CA262589 - T32 Training Program in Pediatric Immuno-Oncology and Immunotherapy
St. Jude Children'S Research Hospital
FY2025$140,944T32CA272387 - Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors
St. Jude Children'S Research Hospital
FY2024$716,793R01CA262589
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity
Science Translational Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Towbin, MD
St. Jude Children's Research Hospital
Raul Ribeiro, MD
St. Jude Children's Research Hospital
Thomas Merchant, DO
St. Jude Children's Research Hospital
Alberto Pappo, MD
St. Jude Children's Research Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”